Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co-morbidities

Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real-world’ data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital)

(2016) Giuseppe Boriani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart failure registries: how far can we go?

(2016) John Parissis et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reframing the association and significance of co-morbidities in heart failure

(2016) Filippos Triposkiadis et al.   EUROPEAN JOURNAL OF HEART FAILURE

‘Observational medicine’: registries and Electronic Health Recording for science and health systems governance

(2016) Luigi Tavazzi et al.   EUROPEAN JOURNAL OF HEART FAILURE

The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers

(2016) Anne Christine Ruwald et al.   EUROPEAN JOURNAL OF HEART FAILURE

The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database

(2016) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

(2016) Maria G. Crespo-Leiro et al.   EUROPEAN JOURNAL OF HEART FAILURE

Implant rates of cardiac implantable electrical devices in Europe: A systematic literature review

(2016) Cinzia Valzania et al.   HEALTH POLICY

Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality

(2016) Maurizio Landolina et al.   HEART RHYTHM

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials

(2015) P. L. Hess et al.  

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

(2015) Giuseppe Boriani et al.   EUROPACE

REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study

(2015) Stephen J. Greene et al.   EUROPEAN JOURNAL OF HEART FAILURE

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry

(2015) Gerasimos Filippatos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials

(2015) P. L. Hess et al.   Circulation-Cardiovascular Quality and Outcomes

Expenditure and value for money: the challenge of implantable cardioverter defibrillators

(2009) G. Boriani et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

(2008) Jeanne E. Poole et al.   NEW ENGLAND JOURNAL OF MEDICINE